Lista de obras - Mercedes Borge - Dominio Público Uruguay

CCR4 expression in a case of cutaneous Richter’s transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations

artículo científico publicado en 2011

CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients

artículo científico publicado en 2012

CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.

artículo científico publicado en 2010

Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis

artículo científico publicado en 2018

Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages.

artículo científico publicado en 2015

Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment

artículo científico publicado en 2012

Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).

artículo científico publicado en 2016

Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1.

artículo científico publicado en 2012

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.

artículo científico publicado en 2017

SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.

artículo científico publicado en 2007

Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils from CLL patients

artículo científico publicado en 2020

Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction

artículo científico publicado en 2016

Somatic Hypermutation Defects in Common Variable Immune Deficiency

artículo científico publicado en 2017

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

artículo científico publicado en 2017

Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia.

artículo científico publicado en 2015

The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells

scientific article published on 02 September 2011

The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.

artículo científico publicado en 2014

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.

artículo científico publicado en 2016

Lista de obras de Mercedes Borge

CCR4 expression in a case of cutaneous Richter’s transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations

CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients

CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.

Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis

Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages.

Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment

Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).

Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1.

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.

SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.

Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils from CLL patients

Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction

Somatic Hypermutation Defects in Common Variable Immune Deficiency

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia.

The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells

The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.